Baird Financial Group
EDIT icon

Baird Financial Group’s Editas Medicine EDIT Stock Holding History

Baird Financial Group’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.1K Sell
10,169
-10,701
-51% -$22.6K ﹤0.01% 1824
2025
Q4 		$42.8K Sell
20,870
-7,672
-27% -$22.1K ﹤0.01% 1781
2025
Q3 		$99K Sell
28,542
-329
-1% -$918 ﹤0.01% 1774
2025
Q2 		$63.5K Sell
28,871
-1,880
-6% -$3.08K ﹤0.01% 1755
2025
Q1 		$35.7K Hold
30,751
– – ﹤0.01% 1742
2024
Q4 		$39.1K Sell
30,751
-5,234
-15% -$13.3K ﹤0.01% 1739
2024
Q3 		$123K Sell
35,985
-477
-1% -$2.08K ﹤0.01% 1693
2024
Q2 		$170K Buy
36,462
+1,265
+4% +$7.14K ﹤0.01% 1694
2024
Q1 		$261K Buy
35,197
+6,002
+21% +$49.9K ﹤0.01% 1604
2023
Q4 		$296K Buy
29,195
+3,230
+12% +$28.4K ﹤0.01% 1522
2023
Q3 		$203K Buy
25,965
+686
+3% +$5.88K ﹤0.01% 1625
2023
Q2 		$208K Buy
25,279
+218
+0.9% +$1.9K ﹤0.01% 1607
2023
Q1 		$182K Buy
25,061
+7,904
+46% +$70.3K ﹤0.01% 1627
2022
Q4 		$152K Buy
17,157
+6,285
+58% +$69K ﹤0.01% 1628
2022
Q3 		$133K Buy
10,872
+374
+4% +$5.83K ﹤0.01% 1649
2022
Q2 		$125K Sell
10,498
-265
-2% -$3.55K ﹤0.01% 1734
2022
Q1 		$205K Buy
10,763
+800
+8% +$14.9K ﹤0.01% 1745
2021
Q4 		$265K Buy
+9,963
New +$343K ﹤0.01% 1723

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Baird Financial Group's EDIT Position: Q1 2026 in Review

Baird Financial Group reduced its Editas Medicine (EDIT) stake by 51% in Q1 2026, selling an estimated $22.6K and leaving 10,169 shares worth $25.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1824.

Baird Financial Group first reported a position in EDIT in Q4 2021 and has held it in 18 quarters since. The position peaked at $296K in Q4 2023. 207 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

  • Baird Financial Group held 10,169 shares of Editas Medicine worth $25.1K as of Q1 2026.
  • Baird Financial Group sold 10,701 Editas Medicine shares in Q1 2026, an estimated $22.6K.
  • Editas Medicine made up ﹤0.01% of Baird Financial Group's portfolio in Q1 2026, its #1824 holding.
  • Baird Financial Group first reported a position in Editas Medicine in Q4 2021 and has held it in 18 quarters since.
  • Baird Financial Group's Editas Medicine position peaked at $296K in Q4 2023.
  • 207 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Baird Financial Group's 13F filing for Q1 2026, filed 14 May 2026.